A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications

References

• Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7(1):58. .
   PubMedGoogle Scholar
• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PloS One. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• Mayor S. Increase in deaths from antibiotic resistant infections may limit rising longevity, report warns. BMJ. 2016;353:i2845.
   Google Scholar
• Cassini A, Hogberg LD, Plachouras D, et al., Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 19(1): 56–66. 2019. .
   PubMed Web of Science ®Google Scholar
• Hofer U. The cost of antimicrobial resistance. Nature Rev Microbiol. 2019;17(1):3.
   PubMedGoogle Scholar
• Antonanzas F, Goossens H. The economics of antibiotic resistance: a claim for personalised treatments. Eur J Health Econ. 2019;20(4):483–485.
   PubMed Web of Science ®Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al., Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 115(15): E3463–e70. 2018. .
   PubMed Web of Science ®Google Scholar
• Schellack N, Benjamin D, Brink A, et al. A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa. Inter J Infect Dis. 2017;64:100–106.
   PubMed Web of Science ®Google Scholar
• National Department of Health South Africa. SURVEILLANCE FOR ANTIMICROBIAL RESISTANCE AND CONSUMPTION OF ANTIBIOTICS IN SOUTH AFRICA. 2018. [cited 2021 Mar 11]. Available from: http://www.health.gov.za/index.php/antimicrobial-resistance?download=3374:surveillance-for-antimicrobial-resistance
   Google Scholar
• Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; A preliminary study. Front Pharmacol. 2017;8:751.
   PubMed Web of Science ®Google Scholar
• Pillay-van Wyk V, Msemburi W, Laubscher R, et al. Mortality trends and differentials in South Africa from 1997 to 2012: second national burden of disease study. Lancet Glob Health. 2016;4(9):e642–53. .
   PubMed Web of Science ®Google Scholar
• Global, regional, and national burden of tuberculosis, 1990-2016: results from the global burden of diseases, injuries, and risk factors 2016 study. Lancet Infect Dis. 2018;18(12):1329–1349.
   PubMed Web of Science ®Google Scholar
• AVERT. HIV AND AIDS IN SOUTH AFRICA. 2018. [cited 2011 Mar 11]. Available from:https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/south-africa
   Google Scholar
• Mendelson M, Matoso M. THE SOUTH AFRICAN ANTIMICROBIAL RESISTANCE STRATEGY FRAMEWORK. Amr Control. 2015;54–61.
   Google Scholar
• World Health Organisation. Antimicrobial resistance. 2018. [cited 2021 Mar 1]. Available from: http://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
   Google Scholar
• Tornimbene B, Eremin S, Escher M, et al. WHO global antimicrobial resistance surveillance system early implementation 2016-17. Lancet Infect Dis. 2018;18(3):241–242.
   PubMed Web of Science ®Google Scholar
• Interagency Coordination Group on Antimicrobial Resistance. NO TIME TO WAIT: SECURING THE FUTURE FROM DRUG-RESISTANT INFECTIONS - REPORT TO THE SECRETARY-GENERAL OF THE UNITED NATIONS APRIL 2019. [cited 2021 Mar 1]. Available from: https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf?ua=1
   Google Scholar
• Saleem Z, Hassali MA, Hashmi FK. Pakistan’s national action plan for antimicrobial resistance: translating ideas into reality. Lancet Infect Dis. 2018;18(10):1066–1067.
   PubMed Web of Science ®Google Scholar
• Slama TG, Amin A, Brunton SA, et al. A clinician’s guide to the appropriate and accurate use of antibiotics: the council for appropriate and rational antibiotic therapy (CARAT) criteria. Am J Med. 2005;118(Suppl 7A):1s–6s. .
   PubMedGoogle Scholar
• Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ. 2016;94(8):558–a. .
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098.
   PubMed Web of Science ®Google Scholar
• Seale AC, Gordon NC, Islam J, et al. AMR surveillance in low and middle-income settings - a roadmap for participation in the global antimicrobial surveillance system (GLASS). Wellcome Open Res. 2017;2:92.
   PubMedGoogle Scholar
• Department of Health Republic of South Africa. ANTIMICROBIAL RESISTANCE NATIONAL STRATEGY FRAMEWORK 2014-2024. [cited 2021 Mar 1]. Available from: https://www.jpiamr.eu/wp-content/uploads/2018/10/Antimicrobial-Resistance-National-Strategy-Framework-2014-2024_South-Africa.pdf
   Google Scholar
• Versporten A, Bielicki J, Drapier N, et al. The worldwide antibiotic resistance and prescribing in European children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016;71(4):1106–1117. .
   PubMed Web of Science ®Google Scholar
• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
   PubMedGoogle Scholar
• Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl 3):12–15.
   PubMed Web of Science ®Google Scholar
• Robertson J, Iwamoto K, Hoxha I, et al. Antimicrobial medicines consumption in eastern Europe and Central Asia – an updated cross-national study and assessment of quantitative metrics for policy action. Front Pharmacol. 2019;9(1156). https://doi.org/10.3389/fphar.2018.01156.
   Google Scholar
• Abilova V, Kurdi A, Godman B. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Rev Anti Infect Ther. 2018;16(1):77–84.
   PubMed Web of Science ®Google Scholar
• Plachouras D, Karki T, Hansen S, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveillance. 2018;23(46).
   Google Scholar
• Versporten A, Zarb P, Caniaux I, et al., Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 6(6): e619–e29. 2018. .
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750. .
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Godman B, et al., Point prevalence surveys of antimicrobial use: a systematic review and the implications. Expert Rev Anti Infect Ther. 18(9): 897–910. 2020. .
   PubMed Web of Science ®Google Scholar
• Olaru ID, Kibuule D, Godman B. Implications of antibiotic exposure among children in low-income and middle-income countries. Lancet Infect Dis. 2020;20(2):146–147.
   PubMed Web of Science ®Google Scholar
• Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616. .
   PubMedGoogle Scholar
• Massele A, Tiroyakgosi C, Matome M, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):1–4. .
   PubMed Web of Science ®Google Scholar
• Olaru ID, Meierkord A, Godman B, et al. Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe. J Chemother. 2020;32(8):456–459. .
   PubMed Web of Science ®Google Scholar
• Irek EO, Amupitan AA, Obadare TO, et al. A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective. Afr J Lab Med. 2018;7(2):796.
   PubMed Web of Science ®Google Scholar
• Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102. .
   PubMedGoogle Scholar
• Allegranzi B, Bischoff P, De Jonge S, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e276–e87. .
   PubMedGoogle Scholar
• Anand Paramadhas BD, Tiroyakgosi C, Mpinda-Joseph P, et al., Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications. Expert Rev Anti Infect Ther. 17(7): 535–546. 2019. .
   PubMed Web of Science ®Google Scholar
• Saleem Z, Godman B, Hassali MA, et al. Point prevalence surveys of health-care-associated infections: a systematic review. Pathog Glob Health. 2019;113(4):191–205. .
   PubMed Web of Science ®Google Scholar
• Saleem Z, HassaliMA, Versporten A, et al. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019;17(4):285–293. .
   PubMed Web of Science ®Google Scholar
• Al Matar M, Enani M, Binsaleh G, et al. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016. J Infect Public Health. 2019;12(1):77–82.
   PubMed Web of Science ®Google Scholar
• Talaat M, Saied T, Kandeel A, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3(3):450–460.
   Google Scholar
• Shapiro DJ, Hicks LA, Pavia AT, et al. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014;69(1):234–240.
   PubMed Web of Science ®Google Scholar
• Livorsi DJ, Linn CM, Alexander B, et al. The value of electronically extracted data for auditing outpatient antimicrobial prescribing. Infect Control Hosp Epidemiol. 2018;39(1):64–70. .
   PubMed Web of Science ®Google Scholar
• Mashalla Y, Setlhare V, Massele A, et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: findings and implications. Int J Clin Pract. 2017;71(12). https://doi.org/10.1111/ijcp.13042.
   Google Scholar
• Furst J, Cizman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289. .
   PubMed Web of Science ®Google Scholar
• Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66(Suppl 6):vi71–7. .
   PubMedGoogle Scholar
• ECDC.Quality indicators for antibiotic consumption in the community in Europe. [cited 2021 Mar 1]. Available from: http://ecdc.europa.eu/en/healthtopics/antimicrobial-resistance-and-consumption/antimicrobial-consumption/esac-net-database/Pages/quality-indicators-primary-care.aspx
   Google Scholar
• Hsia Y, Sharland M, Jackson C, et al. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. Lancet Infect Dis. 2019;19(1):67–75. .
   PubMed Web of Science ®Google Scholar
• Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe. Lancet Infect Dis. 2018;18(1):18–20. .
   PubMed Web of Science ®Google Scholar
• World Health Organization - Model List of Essential Medicines. 21st List 2019. [cited 2021 Mar 1]. Available from: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1
   Google Scholar
• Matsitse TB, Helberg E, Meyer JC, et al. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther. 2017;15(10):963–972. .
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Campbell S, et al. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm. 2020;42(4):1227–1236.
   PubMed Web of Science ®Google Scholar
• Sharland M, Gandra S, Huttner B, et al., Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 essential medicines list becomes a global antibiotic stewardship tool. Lancet Infect Dis. 19(12): 1278–1280. 2019. .
   PubMed Web of Science ®Google Scholar
• Afriyie DK, Sefah IA, Sneddon J, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;1–9.
   Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721. .
   PubMed Web of Science ®Google Scholar
• Kalaba M, Kosutic J, Godman B, et al. Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries? J Comp Eff Res. 2018;7(3):247–258. .
   PubMed Web of Science ®Google Scholar
• Van Der Sandt N, Schellack N, Mabope LA, et al. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2019;38(2):122–126.
   PubMed Web of Science ®Google Scholar
• Mwita JC, Ogunleye O, Olalekan A, et al. Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low- and middle-income countries: a narrative review and the implications. Int J Gen Med. 2021;14,515–530.
   PubMed Web of Science ®Google Scholar
• Le Maréchal M, Tebano G, Monnier AA, et al. Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018;73(suppl_6):vi40–vi9.
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Massele A, et al. Validity of world health organisation prescribing indicators in namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2019;31(5):338–345.
   PubMed Web of Science ®Google Scholar
• De Bie S, Kaguelidou F, Verhamme KM, et al. Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing. Pediatr Infect Dis J. 2016;35(12):1317–1323. .
   PubMed Web of Science ®Google Scholar
• Budd E, Cramp E, Sharland M, et al. Adaptation of the WHO essential medicines list for national antibiotic stewardship policy in England: being AWaRe. J Antimicrob Chemother. 2019;74(11):3384–3389. .
   PubMed Web of Science ®Google Scholar
• Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107–115. .
   PubMed Web of Science ®Google Scholar
• Dlamini NN, Meyer JC, Kruger D, et al. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications. Hosp Pract. 2019;47(2):88–95. .
   PubMedGoogle Scholar
• Kruger D, Dlamini NN, Meyer JC, et al. Development of a web-based application to improve data collection of antimicrobial utilisation in the public health care system in South Africa. Hosp Pract. 2021. https://doi.org/10.1080/21548331.2021.1889213.
   Google Scholar
• Finlayson HVA, Whitelaw A, Goossens H et al.The global point prevalence survey of antimicrobial consumption and resistance (global-pps): results of antimicrobial prescribing in a South African tertiary hospital. 2016. [cited 2021 Mar 1]. Available from: http://www.global-pps.com/wp-content/uploads/ECCMID-2016_South-Africa.pdf
   Google Scholar
• Opanga SA, Mwang’ombe NJ, Okalebo FA, et al. Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in Kenya: findings and implications. Infect Dis Preve Med. 2017;5:169.
   Google Scholar
• Labi A-K, Obeng-Nkrumah N, Nartey ET, et al. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey. Antimicrob Resist Infect Control. 2018;7(1):15. .
   PubMedGoogle Scholar
• Labi AK, Obeng-Nkrumah N, Owusu E, et al. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect. 2019;101(1):60–68.
   PubMed Web of Science ®Google Scholar
• Okoth C, Opanga S, Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications. Hosp Pract. 2018;46(3):128–136. .
   PubMedGoogle Scholar
• Momanyi L, Opanga S, Nyamu D, et al. Antibiotic prescribing patterns at a leading referral hospital in Kenya: a point prevalence survey. J Res Pharm Pract. 2019;8(3):149–154. .
   PubMed Web of Science ®Google Scholar
• Oduyebo OO, Olayinka AT, Iregbu KC, et al. A point prevalence survey of antimicrobial prescribing in four Nigerian tertiary hospitals. Ann Trop Pathol. 2017;8(1):42–46.
   Google Scholar
• Nsofor CA, Amadi ES, Ukwandu N, et al. Prevalence of antimicrobial use in major hospitals in Owerri, Nigeria. 2016;3.5:522–527. EC MICROBIOLOGY
   Google Scholar
• National Department of Health (NDoH). Regulations relating to categories of hospitals. Government Notices. Pretoria, South Africa. 2012. [cited 2021 Mar 1]. Available from: http://www.health.gov.za/index.php/2014-03-17-09-09-38/legislation/joomla-split-menu/category/84-2012r?download=138:regulations-relating-to-categories-of-hospitals-r185-20122
   Google Scholar
• ECDC. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. [cited 2021 Mar 1]. Available from: http://ecdc.europa.eu/en/publications/Publications/PPS-HAI-antimicrobial-use-EU-acute-care-hospitals-V5-3.pdf
   Google Scholar
• WHO. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. 2020. [cited 2021 Mar 1]. Available from: https://www.whocc.no/
   Google Scholar
• Aiken AM, Wanyoro AK, Mwangi J, et al. Changing use of surgical antibiotic prophylaxis in thika hospital, Kenya: a quality improvement intervention with an interrupted time series design. PloS One. 2013;8(11):e78942. .
   PubMed Web of Science ®Google Scholar
• WHO. WHO methodology for point prevalence survey on antibiotic use in hospitals. Version 1.1. 2019. [cited 2021 Mar 1]. Available from: https://www.who.int/medicines/access/antimicrobial_resistance/WHO-EMP-IAU-2018_01/en/
   Google Scholar
• National department of health, South Africa. essential drugs programme. hospital level (adults) standard treatment guidelines and essential medicines list . 5th ed. 2019. [cited 2021 Mar 1]. Available from: http://www.health.gov.za/index.php/standard-treatment-guidelines-and-essential-medicines-list/category/286-hospital-level-adults
   Google Scholar
• Bergman U, Risinggard H, Vlahovic-Palcevski V, et al. Use of antibiotics at hospitals in Stockholm: a benchmarking project using internet. Pharmacoepidemiol Drug Saf. 2004;13(7):465–471.
   PubMed Web of Science ®Google Scholar
• Goryachkina K, Babak S, Burbello A, et al. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data–application in a Russian hospital. Pharmacoepidemiol Drug Saf. 2008;17(6):636–644. .
   PubMed Web of Science ®Google Scholar
• Bruce J, MacKenzie FM, Cookson B, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64(4):853–860.
   PubMed Web of Science ®Google Scholar
• Stanic Benic M, Milanic R, Monnier AA, et al. Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018;73(suppl_6):vi50–vi8. .
   PubMedGoogle Scholar
• Loyse A, Burry J, Cohn J, et al. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis. 2019;19(4):e143–e7.
   PubMed Web of Science ®Google Scholar
• Van Niekerk L, Raubenheimer PJ. A point-prevalence survey of public hospital inpatients with palliative care needs in Cape Town, South Africa. South Afr Med J. 2014;104(2):138–141.
   PubMed Web of Science ®Google Scholar
• Engler D, Meyer JC, Schellack N, et al. Compliance with South Africa’s antimicrobial resistance national strategy framework: are we there yet? J Chemother. 2021;33(1):21–31. .
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children - supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Mar 2018. Available from: https://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/)
   Google Scholar
• Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680. .
   PubMed Web of Science ®Google Scholar
• Timsit JF, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–189.
   PubMed Web of Science ®Google Scholar
• Saha SK, Shaha KC, Haque MF, et al. Current trends of using antimicrobial drugs in the ICU at a tertiary level teaching hospital in mymensingh. 2016;25(4):657–662. Mymensingh medical journal
   Google Scholar
• Nusrat T, Akter N, Rahman NAA, et al. Antibiotic resistance and sensitivity pattern of metallo-β-lactamase producing gram-negative bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in bangladesh. Hosp Pract. 2020;48(3):128-136.
   Google Scholar
• Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clinl Infect Dis. 2004;38(12):1706–1715.
   PubMed Web of Science ®Google Scholar
• De Jonge SW, Gans SL, Atema JJ, et al. Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(29):e6903. .
   PubMed Web of Science ®Google Scholar
• Dellinger EP. What is the ideal time for administration of antimicrobial prophylaxis for a surgical procedure? Ann Surg. 2008;247(6):927–928.
   PubMed Web of Science ®Google Scholar
• Ban KA, Minei JP, Laronga C, et al. Executive summary of the American college of surgeons/surgical infection society surgical site infection guidelines-2016 update. Surg Infect (Larchmt). 2017;18(4):379–382.
   PubMed Web of Science ®Google Scholar
• NICE. Surgical site infections: prevention and treatment treatment. NICE CG 74. 2008. Available from: https://www.nice.org.uk/guidance/cg74/resources/surgical-site-infections-prevention-and-treatment-pdf-975628422853
   Google Scholar
• Cooper L, Sneddon J, Afriyie DK, et al. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis. JAC-Antimicrobial Resistance. 2020;2(3). DOI: https://doi.org/10.1093/jacamr/dlaa070.
   Google Scholar